Literature DB >> 12895318

[Clinical features and therapy of 106 cases of severe acute respiratory syndrome].

Zheng-yin Liu1, Tai-sheng Li, Zhong Wang, Zuo-jun Xu, Huan-ling Wang, Ying Yu, Tie-kuan Du, Yan Bai, Zhi-feng Qiu, Wei Lü, Hong-wei Fan, Xiao-jun Ma, Bao-tong Zhou, Ai-xia Wang, Bai-qiang Cai, Guo-hua Deng, An-ping Ni.   

Abstract

OBJECTIVE: To investigate the clinical characteristics of severe acute respiratory syndrome (SARS) and find out its effective treatment.
METHODS: A total of 106 cases of SARS were analyzed prospectively.
RESULTS: In this group, 56 were male and 50 female, aged from 15 to 81 years [average (36 +/- 10) years]. Common symptoms included fever (98.1%), chills (75.5%), cough (71.7%), headache and breathless (both 43.4%), diarrhea (24.5%) and rare rales in the lungs (11.2%). Laboratory test showed leukopenia (34.0%), lymphopenia (81.1%) and an extraordinary decrease of CD(4)(+) T cells (98.1%). Other rare abnormalities included liver injury (elevated alanine aminotransferase in 7.6%) and thrombocytopenia (3.8%). Almost all patients suffered from hypoxemia (PaO(2) less than 90 mm Hg in 90.2%, less than 70 mm Hg in 28.6%). Chest radiographs showed that unilateral focal patchy involvement in 34.0% of the patients, and unilateral multifocal or bilateral involvement were 11.3% and 46.2% respectively. Treatment regimens included small doses of steroids (methylprednisolone 40-80 mg, q12 h recommended) accompanied with broad-spectrum antibiotics such as the second generation of cephalosporins and macrolides and some other antiviral drugs. Meanwhile, emphasis was placed on oxygen support and coping with their underlying diseases.
CONCLUSIONS: SARS has various presentations of clinical features and laboratory tests. Detection of CD(4)(+) T cell count is beneficial to diagnose SARS in early stage. Effective treatment includes various regimens, oxygen support and small doses of steroids.

Entities:  

Mesh:

Year:  2003        PMID: 12895318

Source DB:  PubMed          Journal:  Zhonghua Nei Ke Za Zhi        ISSN: 0578-1426


  5 in total

1.  Short term outcome and risk factors for mortality in adults with critical severe acute respiratory syndrome (SARS).

Authors:  Xianming Hu; Yongzhi Deng; Jun Wang; Heping Li; Mei Li; Zuxun Lu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2004

Review 2.  COVID-19, MERS and SARS with Concomitant Liver Injury-Systematic Review of the Existing Literature.

Authors:  Michał Kukla; Karolina Skonieczna-Żydecka; Katarzyna Kotfis; Dominika Maciejewska; Igor Łoniewski; Luis F Lara; Monika Pazgan-Simon; Ewa Stachowska; Mariusz Kaczmarczyk; Anastasios Koulaouzidis; Wojciech Marlicz
Journal:  J Clin Med       Date:  2020-05-11       Impact factor: 4.241

Review 3.  SARS-CoV-2 reinfection and implications for vaccine development.

Authors:  Firzan Nainu; Rufika Shari Abidin; Muh Akbar Bahar; Andri Frediansyah; Talha Bin Emran; Ali A Rabaan; Kuldeep Dhama; Harapan Harapan
Journal:  Hum Vaccin Immunother       Date:  2020-12-01       Impact factor: 3.452

4.  Hypothesis for potential pathogenesis of SARS-CoV-2 infection-a review of immune changes in patients with viral pneumonia.

Authors:  Ling Lin; Lianfeng Lu; Wei Cao; Taisheng Li
Journal:  Emerg Microbes Infect       Date:  2020-12       Impact factor: 7.163

5.  Simulating the SARS outbreak in Beijing with limited data.

Authors:  Wendi Wang; Shigui Ruan
Journal:  J Theor Biol       Date:  2004-04-07       Impact factor: 2.691

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.